Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 235,260 | 413,083 | 885,562 | 46,535 | 32,694 |
| Marketable Securities | 848,577 | 1,078,257 | 504,544 | 368,515 | 190,096 |
| Receivables | 865 | N/A | N/A | N/A | N/A |
| Inventories | 3,020 | N/A | N/A | N/A | N/A |
| Other current assets | 21,239 | 16,643 | 13,537 | 9,357 | 3,870 |
| TOTAL | $1,108,961 | $1,507,983 | $1,403,643 | $424,407 | $226,660 |
| Non-Current Assets | |||||
| PPE Net | 17,540 | 15,824 | 7,809 | 1,776 | 473 |
| Investments And Advances | 3,465 | 8,218 | 15,629 | 0 | 0 |
| Intangibles | 14,914 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 57,767 | 56,729 | 49,047 | 6,017 | 1,321 |
| TOTAL | $93,686 | $80,771 | $72,485 | $7,793 | $1,794 |
| Total Assets | $1,202,647 | $1,588,754 | $1,476,128 | $432,200 | $228,454 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 38,861 | 35,163 | 18,117 | 48,082 | 25,775 |
| Accrued Expenses | 120,587 | 108,495 | 53,355 | N/A | N/A |
| TOTAL | $159,448 | $143,658 | $71,472 | $48,906 | $26,146 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 824 | 371 |
| Other Non-Current Liabilities | 46,683 | 48,058 | 43,867 | 999 | 0 |
| TOTAL | $46,683 | $48,058 | $43,867 | $999 | $732 |
| Total Liabilities | $206,131 | $191,716 | $115,339 | $49,905 | $26,878 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,038 | 55,488 | 50,634 | 43,480 | 35,268 |
| Common Shares | 58 | 55 | 50 | 40 | 33 |
| Retained earnings | -2,452,889 | -1,712,022 | -1,130,238 | -772,301 | -559,045 |
| Other shareholders' equity | -3,719 | 9,068 | 9,759 | 9,889 | 9,479 |
| TOTAL | $996,516 | $1,397,038 | $1,360,789 | $382,295 | $201,576 |
| Total Liabilities And Equity | $1,202,647 | $1,588,754 | $1,476,128 | $432,200 | $228,454 |